glyburide has been researched along with glimepiride in 138 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.72) | 18.7374 |
1990's | 30 (21.74) | 18.2507 |
2000's | 57 (41.30) | 29.6817 |
2010's | 44 (31.88) | 24.3611 |
2020's | 6 (4.35) | 2.80 |
Authors | Studies |
---|---|
Grell, W; Griss, G; Hurnaus, R; Luger, P; Mark, M; Müller, P; Nar, H; Rupprecht, E; Sauter, R; Wittneben, H | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bergström, CA; Hubatsch, I; Johansson, K; Wassvik, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kume, S; Ozaki, Y; Yatomi, Y | 1 |
Lebrun, P; Malaisse, WJ | 1 |
Akkan, AG; Ledercq-Meyer, V; Malaisse, WJ; Marchand, J | 1 |
Doi, K | 1 |
Geisen, K | 1 |
Mnner, K; Panten, U; Schwanstecher, M | 1 |
Crecelius, A; Müller, G; Pünter, J; Unkelbach, A; Wetekam, EM; Wied, S | 1 |
Hartz, D; Kramer, W; Müller, G; Okonomopulos, R; Pünter, J | 1 |
Girbig, F; Gutjahr, U; Hartz, D; Kowalewski, S; Kramer, W; Müller, G; Summ, HD | 2 |
Lebrun, P; Malaisse, WJ; Sener, A | 1 |
Brasseur, R; Lins, L; Malaisse, WJ | 1 |
Bijlstra, PJ; Lutterman, JA; Russel, FG; Smits, P; Thien, T | 1 |
Draeger, KE; Lomp, HJ; Rosskamp, R; Schüler, E; Wernicke-Panten, K | 1 |
Dills, DG; Schneider, J | 1 |
Clark, HE; Matthews, DR | 1 |
Herz, M; Massi-Benedetti, M; Pfeiffer, C | 1 |
Geisen, K; Kramer, W; Müller, G | 1 |
Geisen, K; Krause, E; Papp, JG; Végh, A | 1 |
Bozdogan, O; Leprán, I; Papp, JG | 1 |
Smits, P | 1 |
Grell, W; Mark, M | 1 |
Fuhlendorff, J; Ladrière, L; Malaisse, WJ; Malaisse-Lagae, F | 1 |
Kaneko, T; Sakamoto, N | 1 |
Brogard, JM | 1 |
Rocchetti, M; Rosati, B; Wanke, E; Zaza, A | 1 |
Baczkó, I; Bozdogan, O; El-Reyani, NE; Leprán, I; Papp, JG | 1 |
Amann, FW; Boedeker, KH; Burger, W; Gruber, D; Harris, S; Kiowski, W; Klepzig, H; Kober, G; Luus, H; Matter, C; Schneider, H | 1 |
Dimitriadis, G; Draeger, KE; Hatziagelaki, E; Pfeiffer, C; Raptis, AE; Raptis, SA | 1 |
Henke, B; Lindner, S; Müller, M; Mutschler, E; Olbrich, HG; Oremek, G; Riehle, M; Zarse, M | 1 |
Riddle, M | 1 |
Baczkó, I; El-Reyani, NE; Leprán, I; Papp, JG | 1 |
Filipiak, KJ | 1 |
Brunelli, C; Cordera, R; Cordone, S; Olivotti, L; Rossettin, P; Schiavo, M; Spallarossa, P | 1 |
Houston, RJ; Legtenberg, RJ; Oeseburg, B; Smits, P | 1 |
Baxter, GF; Lawrence, CL; Maddock, HL; Mocanu, MM; Standen, NB; Yellon, DM | 1 |
Abbink, EJ; Jansen van Rosendaal, A; Lutterman, JA; Pickkers, P; Russel, FG; Smits, P; Tack, CJ | 1 |
Hu, S | 1 |
Kocsis, E; Koltai, MZ; Nieszner, E; Pogátsa, G; Pósa, I | 1 |
Cascorbi, I; Kivistö, KT; Kroemer, HK; Neuvonen, PJ; Niemi, M; Timm, R | 1 |
Nakamura, N | 1 |
Bachmann, O; Dahl, D; Häring, HU; Haupt, A; Kausch, C; Matthaei, S; Stumvoll, M | 1 |
Chou, TF; Lee, TM | 1 |
Auclair, J; Bouskela, E; Félétou, M; Levens, N; Néliat, G; Ravel, D | 1 |
Egberts, EH; Hammer, C; Holstein, A; Plaschke, A | 1 |
Bataille, D | 1 |
Beuth, J; Kolb, H; Martin, S; Scherbaum, WA; Schneider, B; van Leendert, R | 1 |
Komiya, H; Kurokawa, N; Mori, Y; Tajima, N | 1 |
Clifton-Bligh, RJ; Veitch, PC | 1 |
Riddle, MC | 1 |
Abe, Y; Matsumoto, K; Miyake, S; Sera, Y; Tominaga, T; Yeki, Y | 1 |
Fukuen, S; Iwaki, M; Makishima, M; Matsuda, M; Shimomura, I; Yasui, A | 1 |
Awata, T; Inukai, K; Kashiwabara, H; Katayama, S; Kurihara, S; Nakashima, Y; Sawa, T; Suzuki, M; Takata, N; Tanaka, M; Watanabe, M; Yokota, K | 1 |
Charpentier, G; Clerson, P; Dubroca, I; Fleury, F; Vaur, L | 1 |
Brockmöller, J; Egberts, EH; El-Din, J; Holstein, A; Kirchheiner, J; Plaschke, A; Ptak, M | 1 |
Martin, S | 1 |
Hashimoto, S; Ishikawa, SE; Kawakami, M; Kuroki, M; Saito, M; Ueba, H; Umemoto, T; Yasu, T | 1 |
Cryer, PE; Fender, AB; Gerich, JE; Gosmanov, NR; Meyer, C; Nihalani, A; Sinkin, JC; Szoke, E | 1 |
Hashizume, K; Komatsu, M | 1 |
Kobayashi, K; Kobayashi, M; Kojima, M; Maruyama, I; Maruyama, K; Ojima, K; Shibata, N; Tomiyama, Y; Yamazaki, Y | 1 |
Ito, S; Koshiba, K; Nakaya, Y; Nomura, M | 1 |
Aoyagi, I; Fujimori, Y; Fuujimori, Y; Itoh, Y; Kojima, M; Kojima, S; Kusama, H; Mori, Y; Ojima, K; Shibata, N; Tajima, N; Yamazaki, Y | 1 |
El Deeb, S; Schepers, U; Wätzig, H | 1 |
Hashimoto, Y; Iwakawa, S; Kuroda, T; Miyashita, K | 1 |
El Deeb, S; Preu, L; Wätzig, H | 1 |
Jin, SH; Li, ZR; Shi, YQ; Yao, J | 1 |
Kimura, T; Kita, M; Suzuma, K; Takagi, H; Watanabe, D; Yoshimura, N | 1 |
Chakradhar, L; Kallem, R; Karthik, A; Mullangi, R; Ramesh, S; Srinivas, NR; Sundari, BT | 1 |
Basu, A; Basu, R; Charkoudian, N; Joyner, MJ; Rizza, RA; Schrage, W | 1 |
Bhattacharya, SK; Das, BP; Madhu, SV; Mahajan, P; Paudel, KR; Rauniar, GP; Shastri, S; Tripathi, AK | 1 |
Li, J; Wang, L; Wu, GT; Zhu, WZ | 1 |
Krishnarajah, G; Lyu, R; Mavros, P; Vexiau, P; Yin, D | 1 |
El Deeb, S; Kaminski, L; Wätzig, H | 1 |
Hattori, Y; Hirama, N; Jojima, T; Suzuki, K; Uchida, K | 1 |
Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Morinaga, H; Nomura, M; Sasaki, S; Sawada, F; Takayanagi, R; Tsubouchi, H | 1 |
Tayek, J | 1 |
Birnbaum, Y; Lin, Y; Perez-Polo, JR; Ye, Y | 1 |
Argaud, L; Couture-Lepetit, E; Garrier, O; Gateau-Roesch, O; Gomez, L; Loufouat, J; Ovize, M; Robert, D | 1 |
Khalangot, M; Kovtun, V; Kravchenko, V; Tronko, M | 1 |
Ee, JW; Kwon, SW; Lee, J; Lee, WJ; Park, JH; Shaodong, J | 1 |
Du, W; Huang, QX; Liu, L; Liu, YH; Xie, XM; Xu, DY; Zhao, SP | 1 |
Böhm, R; Cascorbi, I; Herdegen, T | 1 |
Arai, K; Hirao, K; Kanamori, A; Matoba, K; Matsuba, I; Mori, H; Takai, M; Takeda, H; Terauchi, Y; Yamauchi, M | 1 |
Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 2 |
Hahn, M; Hammer, C; Holstein, A; Kovacs, P; Kulamadayil, NS | 1 |
Bełtowski, J; Jamroz-Wiśniewska, A; Marciniak, A; Wójcicka, G; Łowicka, E | 1 |
Heikkilä, P; Huupponen, R; Laine, K; Tirkkonen, T | 1 |
Ban, N; Endo, K; Kawana, H; Miyashita, Y; Nagayama, D; Ohira, M; Oyama, T; Saiki, A; Shirai, K; Yamaguchi, T | 1 |
Kaneto, H; Katakami, N; Matsuhisa, M; Shimomura, I; Yamasaki, Y | 1 |
Bhavsar, DD; Charakida, M; Deanfield, JE; Loukogeorgakis, SP; MacAllister, RJ; Okorie, MI; Ridout, D | 1 |
Kara, M; Proschak, E; Schneider, G; Schubert-Zsilavecz, M; Steinhilber, D; Steri, R | 1 |
Celner, J; Enzmann, H; Haas, B; Mayer, P; Pfeifer, A | 1 |
Andersson, C; Gislason, GH; Hansen, PR; Jørgensen, CH; Køber, L; Mérie, C; Norgaard, ML; Olesen, JB; Schmiegelow, M; Sørensen, R; Torp-Pedersen, C; Vaag, A; Weeke, P | 1 |
Burns, BD; Levine, M; Lovecchio, F; Pizon, AF; Riley, BD; Ruha, AM; Thomas, SH | 1 |
Abdelmoneim, AS; Brocks, DR; Hasenbank, SE; Light, PE; Seubert, JM; Simpson, SH | 1 |
Bernhardt, R; Hannemann, F; Hutter, M; Kleser, M; Zapp, J | 1 |
Fatehi, M; Lang, VY; Light, PE | 1 |
Arrigain, S; Atreja, A; Jain, A; Kattan, MW; Nutter, B; Pantalone, KM; Wells, BJ; Yu, C; Zimmerman, RS | 1 |
Dyrskjøt, L; Grimm, D; Magnusson, NE; Pietsch, J; Rungby, J; Wehland, M | 1 |
Bader, G; Dworak, M; Giani, G; Gruenberger, JB; Kostev, K; Rathmann, W | 1 |
Kimura, H; Masuda, S; Sato, D; Sato, Y | 1 |
Bruce, SS; Connolly, ES; Heyer, EJ; Mergeche, JL | 1 |
Chang, MP; Chen, CC; Hung, YC; Lin, CC; Sung, FC; Wang, TY | 1 |
Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A | 1 |
Davis, SN; Joy, NG; Tate, DB | 1 |
Bilker, WB; Brensinger, CM; Cardillo, S; Flockhart, DA; Flory, JH; Gagne, JJ; Han, X; Hennessy, S; Leonard, CE | 1 |
Ito, R; Matsuda, K; Miyawaki, K; Suzuki, M; Takeuchi, K; Tsujihata, Y | 1 |
Kuwata, H; Seino, Y; Yabe, D | 1 |
Ali, Z; Daniyal, M; Naveed, S; S I, I; Usmanghani, K | 1 |
Bilker, WB; Brensinger, CM; Chiang, C; Han, X; Hennessy, S; Leonard, CE; Li, L | 1 |
Bellone, JM; Ruhland, DJ; Wilkes, E | 1 |
Aquilante, CL; Bilker, WB; Boudreau, DM; Brensinger, CM; Deo, R; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Mangaali, MJ | 1 |
Chen, SH; Liu, XN; Peng, Y; Sun, QY | 1 |
Dong, J; Liao, L; Shen, X; Xie, T; Xu, C; Zhang, R; Zhou, X; Zou, Z | 1 |
Huang, HK; Yeh, JI | 1 |
Bahtiri, E; Begolli, L; Blaslov, K; Car, N; Emini-Sadiku, M; Haliti, E | 1 |
Bilker, WB; Brensinger, CM; Dawwas, GK; Dhopeshwarkar, N; Flory, JH; Gagne, JJ; Hennessy, S; Leonard, CE; Soprano, SE | 1 |
Chiriac, FL; Iancu, VI; Radu, GL; Scutariu, RE | 1 |
Bilker, WB; Brensinger, CM; Flory, JH; Hee Nam, Y; Hennessy, S; Leonard, CE | 1 |
Berry, SD; Hayes, KN; Munshi, MN; Riester, MR; Zullo, AR | 1 |
Gayakvad, B; Kothari, C; Patel, C; Patel, R; Solanki, R; Wadhwana, P | 1 |
Jannetto, PJ; Langman, LJ | 1 |
17 review(s) available for glyburide and glimepiride
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Line; Cell Membrane; Glyburide; Humans; Hypoglycemic Agents; Islets of Langerhans; Kinetics; Models, Biological; Pancreatic Neoplasms; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors | 1995 |
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Membrane; Glucose; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors | 1996 |
Cardiovascular effects of sulphonylurea derivatives.
Topics: Adenosine Triphosphate; Animals; Cardiovascular System; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Potassium Channels; Sulfonylurea Compounds | 1997 |
[Clinical efficacy of glimepiride].
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Sulfonylurea Compounds; Vascular Resistance | 1997 |
Combining sulfonylureas and other oral agents.
Topics: Acarbose; Administration, Oral; Carbamates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds | 2000 |
[Sulphonylurea derivatives and the cardiovascular system].
Topics: Animals; Cardiovascular System; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Potassium Channels; Sulfonylurea Compounds | 2000 |
[Glimepiride].
Topics: Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors | 2002 |
[Molecular mechanisms of insulin secretion].
Topics: Animals; Calcium Signaling; Exocytosis; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; Potassium; Potassium Channels; Sulfonylurea Compounds | 2002 |
Long-acting sulfonylureas -- long-acting hypoglycaemia.
Topics: Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Drug Monitoring; Fatal Outcome; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Sulfonylurea Compounds | 2004 |
Timely initiation of basal insulin.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin, Long-Acting; Postprandial Period; Sulfonylurea Compounds | 2004 |
[Retrolective study design -- a new tool of evidence-based medicine].
Topics: Blood Glucose; Blood Glucose Self-Monitoring; Body Weight; Cohort Studies; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Glyburide; Humans; Hypoglycemic Agents; Observation; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results; Sulfonylurea Compounds | 2005 |
[Knack of treatment with oral hypoglycemic drugs in the elderly].
Topics: Aged; Biguanides; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazolidinediones | 2006 |
[Hypoglycemic risk of insulinotropic drugs].
Topics: Blood Glucose; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Risk; Sulfonylurea Compounds | 2009 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohexanes; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Isoindoles; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Nateglinide; Phenylalanine; Piperidines; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Risk Factors; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.
Topics: Animals; Asian People; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Mice; Rats; Risk Factors; Sulfonylurea Compounds; Treatment Outcome | 2016 |
Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Exenatide; Female; Glyburide; Humans; Male; Metformin; Network Meta-Analysis; Pioglitazone; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Vildagliptin | 2019 |
18 trial(s) available for glyburide and glimepiride
Article | Year |
---|---|
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.
Topics: Adult; Analysis of Variance; Blood Pressure; Diazoxide; Forearm; Glyburide; Humans; Hypoglycemic Agents; Injections, Intra-Arterial; Male; Muscle, Smooth, Vascular; Nitroprusside; Potassium Channels; Reference Values; Regional Blood Flow; Sulfonylurea Compounds; Vasodilation; Vasodilator Agents | 1996 |
Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds | 1996 |
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1996 |
The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Clamp Technique; Glyburide; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Placebos; Sulfonylurea Compounds | 1996 |
The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1996 |
Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Double-Blind Method; Electrocardiography; Female; Glyburide; Humans; Hypoglycemic Agents; Injections, Intravenous; Ischemic Preconditioning; Male; Middle Aged; Sulfonylurea Compounds; Treatment Outcome | 1999 |
Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Double-Blind Method; Fasting; Food; Glyburide; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Middle Aged; Placebos; Sulfonylurea Compounds | 1999 |
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.
Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Forearm; Gliclazide; Glyburide; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Ischemia; Male; Metformin; Middle Aged; Reference Values; Regional Blood Flow; Sulfonylurea Compounds; Ultrasonography | 2001 |
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.
Topics: Acetylcholine; Adult; Aged; Blood Flow Velocity; Blood Pressure; Body Mass Index; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diazoxide; Dipyridamole; Double-Blind Method; Female; Forearm; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Vasodilation | 2002 |
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrospective cohort study.
Topics: Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Cohort Studies; Diabetes Mellitus, Type 2; Female; Germany; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triglycerides | 2003 |
Efficacy of glimepiride in Japanese type 2 diabetic subjects.
Topics: Aged; Asian People; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Logistic Models; Male; Middle Aged; Obesity; Retreatment; Sulfonylurea Compounds; Treatment Outcome | 2005 |
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Monitoring; Drug Packaging; Electronics, Medical; Female; France; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Sulfonylurea Compounds | 2005 |
Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucose; Glyburide; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Kinetics; Male; Sulfonylurea Compounds | 2006 |
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis.
Topics: Adipocytes; Aged; Atherosclerosis; Cytokines; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Sulfonylurea Compounds | 2006 |
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
Topics: Acetylcholine; Adult; Blood Glucose; C-Reactive Protein; Drug Interactions; Endothelium, Vascular; Female; Forearm; Glucagon-Like Peptide 1; Glyburide; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Nitroprusside; Plethysmography; Regional Blood Flow; Sulfonylurea Compounds; Vasodilator Agents | 2007 |
Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Ankle; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Sulfonylurea Compounds; Vascular Resistance; Vascular Stiffness | 2010 |
Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Leptin; Male; Pancreatic Polypeptide; Single-Blind Method; Sulfonylurea Compounds | 2015 |
The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes.
Topics: Adiponectin; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Prospective Studies; Sulfonylurea Compounds | 2019 |
103 other study(ies) available for glyburide and glimepiride
Article | Year |
---|---|
Repaglinide and related hypoglycemic benzoic acid derivatives.
Topics: Administration, Oral; Animals; ATP-Binding Cassette Transporters; Benzoates; Blood Glucose; Carbamates; Crystallography, X-Ray; Female; Glyburide; Hypoglycemic Agents; Models, Molecular; Molecular Conformation; Piperidines; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Receptors, Drug; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors | 1998 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Poorly soluble marketed drugs display solvation limited solubility.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Principal Component Analysis; Solubility; Tandem Mass Spectrometry; Thermodynamics | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Effects of oral hypoglycaemic agents on platelet functions.
Topics: Arachidonic Acid; Calcium; Dose-Response Relationship, Drug; Fura-2; Gliclazide; Glyburide; Humans; Ionomycin; Platelet Activation; Platelet Aggregation Inhibitors; Sulfonylurea Compounds | 1992 |
Cationic and secretory effects of glimepiride and glibenclamide in perifused rat islets.
Topics: Animals; Calcium Radioisotopes; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Islets of Langerhans; Perfusion; Rats; Rubidium Radioisotopes; Sulfonylurea Compounds | 1992 |
Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
Topics: Animals; Female; Glucagon; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Time Factors | 1991 |
[New oral antidiabetic agents].
Topics: Animals; Cyclohexanols; Diabetes Mellitus; Drug Evaluation; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Imidazoles; Insulin; Insulin Secretion; Molecular Structure; Pyrrolidines; Stimulation, Chemical; Sulfonylurea Compounds | 1990 |
Special pharmacology of the new sulfonylurea glimepiride.
Topics: Administration, Oral; Animals; Blood Glucose; Chemical Phenomena; Chemistry; Dogs; Female; Glucagon; Glucose; Glyburide; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Lactates; Male; Pancreas; Rabbits; Rats; Somatostatin; Sulfonylurea Compounds | 1988 |
Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Topics: Animals; Electrophysiology; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Mice; Microsomes; Potassium Channels; Sulfonylurea Compounds | 1994 |
Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.
Topics: 3T3 Cells; Adipocytes; Animals; Biological Transport; Cyclic AMP; Diaphragm; Enzymes; Glucose; Glyburide; Glycogen; Lipids; Male; Mice; Rats; Rats, Wistar; Sulfonylurea Compounds | 1994 |
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Diabetes Mellitus, Type 2; Glyburide; Hypoglycemic Agents; Kinetics; Pancreas; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Tritium | 1994 |
Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Topics: Affinity Labels; Animals; ATP-Binding Cassette Transporters; Binding Sites; Carrier Proteins; Cell Line; Cell Membrane; Glyburide; Hypoglycemic Agents; Pancreas; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tritium | 1994 |
Modulation of the insulinotropic action of glibenclamide and glimepiride by nutrient secretagogues in pancreatic islets from normoglycemic and hyperglycemic rats.
Topics: Animals; B-Lymphocytes; Calcium; Carbon Dioxide; Diabetes Mellitus, Type 2; Glucose; Glyburide; Hyperglycemia; In Vitro Techniques; Insulin; Islets of Langerhans; Perfusion; Rats; Succinates; Sulfonylurea Compounds; Water | 1993 |
Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
Topics: Benzamides; Carbamates; Cyclohexanes; Drug Design; Glyburide; Hypoglycemic Agents; Indoles; Isoindoles; Molecular Conformation; Nateglinide; Phenylalanine; Piperidines; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds | 1995 |
Cardiovascular effects of conventional sulfonylureas and glimepiride.
Topics: Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; Dogs; Electrocardiography; Female; Gliclazide; Glyburide; Hypoglycemic Agents; Male; Myocardial Ischemia; Potassium Channels; Rats; Rats, Wistar; Sulfonylurea Compounds | 1996 |
Effect of glimepiride and glibenclamide, inhibitors of ATP-dependent K(+)-channel, on ischaemia-reperfusion induced arrhythmias in rats.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Glyburide; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Analysis | 1996 |
Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs.
Topics: Animals; Carbamates; Dogs; Female; Glyburide; Hypoglycemic Agents; Piperidines; Rats; Rats, Wistar; Stereoisomerism; Sulfonylurea Compounds | 1997 |
Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats.
Topics: Administration, Oral; Animals; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Fasting; Female; Glyburide; Hypoglycemic Agents; Insulin; Male; Piperidines; Rats; Rats, Wistar; Sulfonylurea Compounds | 1997 |
[24 years later....].
Topics: Cell Membrane; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Patch-Clamp Techniques; Sulfonylurea Compounds | 1998 |
Sulfonylureas blockade of neural and cardiac HERG channels.
Topics: Action Potentials; Animals; Cation Transport Proteins; Chromans; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glyburide; Guinea Pigs; Humans; Inhibitory Concentration 50; Mice; Myocardium; Neuroblastoma; Neurons; Nisoldipine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Sulfonamides; Sulfonylurea Compounds; Trans-Activators; Transcriptional Regulator ERG; Tumor Cells, Cultured | 1998 |
Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Coronary Vessels; Glyburide; Hypoglycemic Agents; Ligation; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Rate | 1999 |
Glimepiride (Hoe490) inhibits the rilmakalim induced decrease in intracellular free calcium and contraction of isolated heart muscle cells from guinea pigs to a lesser extent than glibenclamide.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Calcium; Chromans; Glyburide; Guinea Pigs; Hypoglycemic Agents; In Vitro Techniques; Myocardial Contraction; Potassium; Potassium Channels; Pyrrolidines; Sulfonylurea Compounds | 1999 |
Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats.
Topics: Animals; Coronary Vessels; Glyburide; Heart Ventricles; Hypoglycemic Agents; Image Processing, Computer-Assisted; Ligation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Survival Analysis | 2000 |
Effects of sulfonylurea derivatives on ischemia-induced loss of function in the isolated rat heart.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dose-Response Relationship, Drug; Glyburide; Heart; In Vitro Techniques; Male; Myocardial Stunning; Rats; Rats, Wistar; Sulfonylurea Compounds | 2001 |
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
Topics: Animals; Diazoxide; Glyburide; Guanosine Triphosphate; Heart; Heart Ventricles; Hemodynamics; Hypoglycemic Agents; In Vitro Techniques; Intracellular Membranes; Ischemic Preconditioning, Myocardial; Male; Membrane Potentials; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Ventricular Function | 2001 |
Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action.
Topics: Adenosine Triphosphate; Animals; Carbamates; Cyclohexanes; Dose-Response Relationship, Drug; Glucose; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Membrane Potentials; Nateglinide; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors | 2002 |
Haemodynamic and metabolic effects of low daily dose sulphonylureas in diabetic dog hearts.
Topics: Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Experimental; Dogs; Female; Glyburide; Heart; Heart Rate; Hemodynamics; Hypoglycemic Agents; Lactic Acid; Male; Myocardial Contraction; Potassium; Pyruvic Acid; Sulfonylurea Compounds | 2002 |
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Female; Genotype; Glyburide; Humans; Hypoglycemic Agents; Male; Polymorphism, Genetic; Statistics, Nonparametric; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sulfonylurea Compounds | 2002 |
Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide.
Topics: Androstadienes; Cell Culture Techniques; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glyburide; Glycogen; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male; Muscle, Skeletal; Sulfonylurea Compounds; Wortmannin | 2002 |
Impairment of myocardial protection in type 2 diabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Chest Pain; Diabetes Mellitus, Type 2; Electrocardiography; Female; Glyburide; Heart Rate; Humans; Hypoglycemic Agents; Ischemic Preconditioning; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Potassium Channels; Prospective Studies; Sulfonylurea Compounds; Vasodilator Agents | 2003 |
Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Cricetinae; Cromakalim; Diazoxide; Drug Interactions; Gliclazide; Glyburide; Guinea Pigs; Hypoglycemic Agents; In Vitro Techniques; Ion Channel Gating; Male; Potassium Channels; Rats; Rats, Wistar; Species Specificity; Sulfonylurea Compounds; Vasodilation; Vasodilator Agents | 2003 |
Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Physicians; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2003 |
Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity.
Topics: Adipose Tissue; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Regulation; Glyburide; Hypoglycemic Agents; Male; Obesity; Rats; Rats, Inbred OLETF; RNA, Messenger; Sulfonylurea Compounds; Tumor Necrosis Factor-alpha | 2004 |
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.
Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Diet Therapy; Drug Administration Schedule; Female; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Japan; Male; Metformin; Middle Aged; Prospective Studies; Sulfonylurea Compounds; Time Factors; Tunica Intima; Tunica Media | 2004 |
Sulfonylurea agents exhibit peroxisome proliferator-activated receptor gamma agonistic activity.
Topics: 3T3-L1 Cells; Animals; Base Sequence; Cell Line; DNA Primers; Glyburide; Humans; Mice; PPAR gamma; Sulfonylurea Compounds | 2005 |
Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Genotype; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Sulfonylurea Compounds | 2005 |
Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway.
Topics: Cells, Cultured; Chromones; Coronary Vessels; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Glyburide; Humans; Hypoglycemic Agents; Morpholines; Nitric Oxide; Oligodeoxyribonucleotides, Antisense; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonylurea Compounds | 2005 |
[Hardly any hypoglycemias, constant weight--and still cost effective].
Topics: Body Weight; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Drugs, Generic; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Sulfonylurea Compounds | 2005 |
Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts.
Topics: Animals; Coronary Circulation; Coronary Vessels; Cromakalim; Dogs; Dose-Response Relationship, Drug; Glyburide; Heart; Hypoglycemic Agents; In Vitro Techniques; Indoles; Isoindoles; Male; Myocardial Reperfusion Injury; Perfusion; Rats; Rats, Wistar; Sulfonylurea Compounds; Time Factors; Vasodilation; Vasodilator Agents | 2006 |
Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Glyburide; Indoles; Insulin; Insulin Secretion; Isoindoles; Lipoprotein Lipase; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Prediabetic State; Rats; Rats, Inbred OLETF; RNA, Messenger; Sulfonylurea Compounds; Triglycerides | 2006 |
Fast HPLC method for the determination of glimepiride, glibenclamide, and related substances using monolithic column and flow program.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Glyburide; Hypoglycemic Agents; Reference Standards; Sulfonylurea Compounds | 2006 |
Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3.
Topics: Aryl Hydrocarbon Hydroxylases; Cell Survival; Cytochrome P-450 CYP2C9; Glyburide; Humans; Hydroxylation; Microsomes, Liver; Recombinant Proteins; Sulfonylurea Compounds; Warfarin | 2006 |
Evaluation of monolithic HPLC columns for various pharmaceutical separations: method transfer from conventional phases and batch to batch repeatability.
Topics: Adrenergic beta-Antagonists; Buffers; Chromatography, High Pressure Liquid; Excipients; Glyburide; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Ophthalmic Solutions; Pharmaceutical Preparations; Pilocarpine; Propranolol; Reference Standards; Reproducibility of Results; Solvents; Sulfonylurea Compounds; Time Factors | 2007 |
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds | 2007 |
Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization.
Topics: Acetylcysteine; Animals; Blood Glucose; Female; Gliclazide; Glyburide; Ischemia; Mice; Oxidative Stress; Oxygen; Retina; Retinal Neovascularization; RNA, Messenger; Sulfonylurea Compounds; Vascular Endothelial Growth Factor A | 2007 |
A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study.
Topics: Acetates; Acetonitriles; Administration, Oral; Animals; Chemical Fractionation; Chromatography, High Pressure Liquid; Glyburide; Humans; Hydrophobic and Hydrophilic Interactions; Hypoglycemic Agents; Male; Methanol; Molecular Structure; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfonylurea Compounds; Tandem Mass Spectrometry | 2008 |
Polymorphonuclear leukocyte function in type-2 diabetes mellitus patients and its correlation with glycaemic control.
Topics: Adult; Aged; Blood Glucose; Chronic Disease; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Immunity, Cellular; Male; Middle Aged; Neutrophils; Respiratory Burst; Sulfonylurea Compounds | 2007 |
Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart.
Topics: Animals; Gliclazide; Glyburide; Heart; Ischemic Preconditioning; Male; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds | 2007 |
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; France; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Stress, Psychological; Sulfonylurea Compounds | 2008 |
Repeatability of monolithic HPLC columns while using a flow program.
Topics: Area Under Curve; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Drug Stability; Glyburide; Hypoglycemic Agents; Models, Chemical; Reference Standards; Reproducibility of Results; Solvents; Sulfonylurea Compounds; Technology, Pharmaceutical; Time Factors | 2008 |
Glimepiride upregulates eNOS activity and inhibits cytokine-induced NF-kappaB activation through a phosphoinoside 3-kinase-Akt-dependent pathway.
Topics: Blotting, Western; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Glyburide; Humans; Hypoglycemic Agents; NF-kappa B; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonylurea Compounds; Tumor Necrosis Factor-alpha; Up-Regulation | 2009 |
Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
Topics: Animals; Apoptosis; Cell Line; Cyclohexanes; Fluoresceins; Gliclazide; Glyburide; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin-Secreting Cells; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; NADPH Oxidases; Nateglinide; Phenylalanine; Protein Kinase C; Reactive Oxygen Species; Sulfonylurea Compounds | 2008 |
SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.
Topics: ATP-Binding Cassette Transporters; Diabetes Mellitus; Glyburide; Humans; Hypoglycemia; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors | 2008 |
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Decanoic Acids; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Glyburide; Hydroxy Acids; Injections, Intravenous; Intubation, Gastrointestinal; KATP Channels; Ligation; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Pioglitazone; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Thiazolidinediones; Ventricular Remodeling | 2008 |
Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+(ATP) opener nicorandil in experimental myocardial infarction.
Topics: Animals; Calcium; Gliclazide; Glyburide; Hemodynamics; Male; Mitochondria; Myocardial Infarction; Nicorandil; Potassium Channel Blockers; Potassium Channels; Rabbits; Sulfonylurea Compounds | 2009 |
Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Factors; Sulfonylurea Compounds; Ukraine | 2009 |
Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs.
Topics: Aerosols; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Light; Reproducibility of Results; Scattering, Radiation; Spectrophotometry, Ultraviolet; Sulfonylurea Compounds | 2010 |
Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Sulfonylurea Compounds; Tissue Plasminogen Activator; Treatment Outcome | 2010 |
Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients.
Topics: Aged; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Family Practice; Gliclazide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Middle Aged; Practice Patterns, Physicians'; Sulfonylurea Compounds; Treatment Outcome | 2010 |
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Sulfonylurea Compounds | 2010 |
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose Self-Monitoring; Comorbidity; Diabetes Mellitus, Type 2; Female; Germany; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Inappropriate Prescribing; Incidence; Independent Living; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Nursing Homes; Patient Education as Topic; Prospective Studies; Sulfonylurea Compounds | 2010 |
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antioxidants; Aryldialkylphosphatase; Diabetes Mellitus, Experimental; Glyburide; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Rats; Rats, Wistar; Spectrophotometry; Streptozocin; Sulfonylurea Compounds | 2010 |
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Hospitalization; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Young Adult | 2010 |
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.
Topics: Aged; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Treatment Outcome | 2011 |
Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore.
Topics: Acetylcholine; Adult; Analysis of Variance; Brachial Artery; Cyclosporine; Endothelium, Vascular; Female; Forearm; Glyburide; Humans; Hyperemia; Ischemic Postconditioning; KATP Channels; Ligation; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Reperfusion Injury; Sulfonylurea Compounds; Vascular Resistance; Vasodilation; Vasodilator Agents; Young Adult | 2011 |
Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription.
Topics: Animals; Chlorocebus aethiops; COS Cells; Genes, Reporter; Glyburide; Hep G2 Cells; Humans; Hypoglycemic Agents; Models, Molecular; Molecular Dynamics Simulation; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sulfonylurea Compounds; Transcriptional Activation | 2010 |
Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes.
Topics: Adipocytes; Cell Differentiation; Cells, Cultured; Gene Expression; Glyburide; Humans; Lipid Metabolism; Polymerase Chain Reaction; Sulfonylurea Compounds; Thiazolidinediones; Triglycerides | 2011 |
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus; Female; Glipizide; Glyburide; Heart Failure; Humans; Hypoglycemic Agents; Male; Sulfonylurea Compounds; Tolbutamide | 2011 |
Hypoglycemia after accidental pediatric sulfonylurea ingestions.
Topics: Accidents, Home; Arizona; Blood Glucose; Child, Preschool; Emergency Service, Hospital; Glipizide; Glucose; Glyburide; Hospitals, Pediatric; Hospitals, Teaching; Hospitals, Urban; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Infant; Poisoning; Retrospective Studies; Sulfonylurea Compounds; Time Factors | 2011 |
CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst.
Topics: Bacillus megaterium; Bacterial Proteins; Blotting, Western; Catalysis; Cytochrome P-450 Enzyme System; DNA Primers; Electrophoresis, Polyacrylamide Gel; Ferredoxin-NADP Reductase; Ferredoxins; Glyburide; Hydroxylation; Kinetics; Magnetic Resonance Spectroscopy; Membrane Proteins; Oxygenases; Plasmids; Schizosaccharomyces; Schizosaccharomyces pombe Proteins; Sulfonylurea Compounds | 2012 |
Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.
Topics: ATP-Binding Cassette Transporters; Chlorpropamide; Cyclohexanes; Diabetes Mellitus, Type 2; Gene Expression Regulation; Gliclazide; Glyburide; Haplotypes; Homozygote; Humans; Isoindoles; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Polymorphism, Single Nucleotide; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Structure-Activity Relationship; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide | 2012 |
The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Topics: Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds | 2012 |
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Metformin; Middle Aged; Propensity Score; Retrospective Studies; Sulfonylurea Compounds; Young Adult | 2012 |
Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell death.
Topics: Animals; Cell Death; Cell Line; Cluster Analysis; Diabetes Mellitus, Type 2; Gene Regulatory Networks; Gliclazide; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Microarray Analysis; Rats; Sulfonylurea Compounds; Up-Regulation | 2012 |
Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.
Topics: Blood Glucose; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Germany; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Middle Aged; Primary Health Care; Retrospective Studies; Sulfonylurea Compounds | 2013 |
Effects of a sitagliptin safety alert on prescription behaviour for oral antihyperglycaemic drugs: a propensity score-matched cohort study of prescription receipt data in Japan.
Topics: Aged; Cohort Studies; Female; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Japan; Logistic Models; Male; Middle Aged; Patient Safety; Practice Patterns, Physicians'; Propensity Score; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2013 |
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.
Topics: Aged; Cognition Disorders; Diabetes Mellitus, Type 2; Endarterectomy, Carotid; Glyburide; Humans; Hypoglycemic Agents; Inflammation; Logistic Models; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2013 |
Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Cardiovascular Diseases; Cohort Studies; Comorbidity; Coronary Disease; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Glyburide; Humans; Hypertension; Hypoglycemic Agents; Incidence; Male; Metformin; Middle Aged; Retrospective Studies; Sulfonylurea Compounds; Taiwan | 2013 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Morbidity; Myocardial Infarction; Piperidines; Registries; Retrospective Studies; Risk Factors; Stroke; Sulfonylurea Compounds; Tolbutamide | 2015 |
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Topics: Aged; Algorithms; Cohort Studies; Drug Interactions; Female; Fenofibrate; Glipizide; Glyburide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sulfonylurea Compounds | 2016 |
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
Topics: Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Glucose Tolerance Test; Glyburide; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; Sulfones; Sulfonylurea Compounds | 2016 |
Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Quality of Life; Sulfonylurea Compounds; Tablets; Treatment Outcome | 2016 |
Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.
Topics: Area Under Curve; Carbamates; Cyclohexanes; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Medical Informatics; Nateglinide; Pharmacoepidemiology; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2017 |
Implementation and Assessment of an Ambulatory Prescribing Guidance Tool to Improve Patient Safety in the Geriatric Population.
Topics: Aged; Ambulatory Care; Decision Support Systems, Clinical; Diabetes Mellitus; Drug Interactions; Glyburide; Humans; Hypoglycemic Agents; Medication Errors; Patient Safety; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prescription Drug Misuse; Sulfonylurea Compounds | 2017 |
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
Topics: Aged; Arrhythmias, Cardiac; Cause of Death; Death, Sudden, Cardiac; Diabetic Angiopathies; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; United States; Ventricular Dysfunction | 2018 |
Different sulfonylureas induce the apoptosis of proximal tubular epithelial cell differently via closing K
Topics: Apoptosis; Cell Line; Epithelial Cells; Gliclazide; Glyburide; Humans; KATP Channels; Kidney Tubules, Proximal; Sulfonylurea Compounds | 2018 |
Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
Topics: Aged; Carbamates; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Mortality; Piperidines; Secretagogues; Sulfonylurea Compounds; Taiwan | 2019 |
Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.
Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Male; Medicaid; Middle Aged; Sulfonylurea Compounds; Treatment Outcome; United States; Ventricular Fibrillation | 2020 |
Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method.
Topics: Chromatography, Liquid; Environmental Monitoring; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Metformin; Reproducibility of Results; Solid Phase Extraction; Sulfonylurea Compounds; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2021 |
Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbamates; Databases, Factual; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Medicaid; Metformin; Middle Aged; Nateglinide; Pharmacoepidemiology; Piperidines; Secretagogues; Sulfonylurea Compounds; United States | 2022 |
Comparative safety of sulfonylureas among U.S. nursing home residents.
Topics: Aged; Female; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Medicare; Myocardial Infarction; Nursing Homes; Retrospective Studies; Stroke; United States | 2023 |
Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Humans; Metformin; Nitrosamines; Pharmaceutical Preparations; Tandem Mass Spectrometry | 2023 |
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide | 2024 |